Andrea Lau
Director, Health Technology Assessment (HTA) and Clinical Evaluation
Andrea Lau - Director, Health Technology Assessment (HTA) and Clinical Evaluation
MSc, Biochemistry, University of Ottawa, Ottawa, Ontario, Canada
BSc, Biochemistry, Queen’s University, Kingston, Ontario, Canada
Andrea Lau is a Director, Health Technology Assessment (HTA) and Clinical Evaluation at PDCI. Her role includes evaluating and summarizing scientific information to form the basis of the clinical components of market access assessments, PMPRB pricing strategies, and reimbursement submissions.
Andrea brings with her over 5 years of experience in clinical research and basic research. Prior to joining PDCI in September 2016, Andrea worked as a Clinical Researcher at the Canadian Agency for Drugs and Technologies in Health, where she reviewed drug submissions in a wide range of therapeutic areas for the purpose of informing reimbursement decisions by Canada’s public drug plans.